Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-response and safety study of Cofact for reversal of vitamin K antagonist anticoagulation in healthy volunteers
NL-OMON51966Phase 2Completed
- Sponsor
- Prothya Biosolutions
- Start
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of Human prothrombin complex in Bleeding (4 arms), sponsored by Prothya Biosolutions. Primary endpoint: Dose-response relationship for Cofact with respect to thrombin generation. Started Nov 2021; status: completed.
02
Drugs
Human prothrombin complex
03
Conditions
Bleeding
Beyond the preview
Go deeper on NL-OMON51966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51966.